Latest News and Press Releases

HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next...

Dublin, April 14, 2025 (GLOBE NEWSWIRE) -- The "European Pharma Handbook 2025" has been added to ResearchAndMarkets.com's offering. The European Pharma Handbook provides pharmaceutical industry...

Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Top 6 Growth Opportunities in Pharma-Biotech, 2025" report has been added to ResearchAndMarkets.com's offering.The pharmaceutical and biotechnology...

Pre-Clinical Study in Collaboration with Netherlands Cancer Instituteis in addition to LIXTE’s Ongoing Clinical Trials for Ovarian and Colorectal Cancers PASADENA, Calif., March 31, 2025 (GLOBE...

Lakewood, CO, March 24, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL), a diversified holding company operating through its subsidiaries KRTL Biotech, Inc. and KRTL International...

– Continued progress in pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) toward first subject treated, on track to take place in the first quarter of 2025 – Multiple subjects currently...

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Pharma 4.0 - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Pharma 4 was valued...

HOUSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates...

Dublin, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The "International Directory of Pharmaceutical Companies 2025" has been added to ResearchAndMarkets.com's offering. The International Directory of...

Dublin, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The "Top 1000 Major Pharmaceutical Companies 2025" directory has been added to ResearchAndMarkets.com's offering. Essential for those doing business in...